Measurement of GABA and glycine in planarians

Pharmacologyonline

Volumn 1, Issue , 2007, Pages 1-7

  Rawls, Scott M ^a   Stagliano, Gregory W ^a   Gomez, Teresa ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Amino acids; HPLC; Method; Planaria

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID RECEPTOR AFFECTING AGENT; ASPARTIC ACID; CYSTINE; EDETATE SODIUM; GLYCINE; PERCHLORIC ACID;

ARTICLE; CONTROLLED STUDY; DERIVATIZATION; EXTRACTION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; REACTION TIME; TURBELLARIA;

EID: 34248375698     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Welsh JH, Moorhead M. The quantitative distribution of 5-hydroxytryptamine in the invertebrates, especially in their nervous systems. J New Drugs 1960;6:146-169.
2. Welsh JH, Williams LD. Monoamine-containing neurons in planaria. J Comp Neurol 1970; 138:103-115.
3. Venturini G, Carolei A, Palladini G, Margotta V, Lauro MG. Radioimmunological and immuneocytochemical demonstration of Met-enkephalin in planaria. Comp Biochem Physiol C 1983;74:23-25.
4. Gustafsson MK: Cestode neurotransmitters. Parasitol. Today 1985;1:72-75.
5. Umeda S, Stagliano G, Borenstein MR, Raffa RB. A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Meth 2005;51:73-76.
6. Cebrià F, Kudome T, Nakazawa M, Mineta K, Ikeo K, Gojobori T, Agata K. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech Develop 2002; 116:199-204.
7. Webb RA, Eklove H. Demonstration of intense glutamate-like immunoreactivity in the longitudinal nerve cords of the cestode Hymenolepis diminuta. Parasitol Res 1989;75:545-548.
8. Itoh MT, Igarashi J. Circadian rhythm of serotonin levels in planarians. Neuroreport 2000; 11: 473-476.
9. de Montigny P, Stobaugh JF, Givens RS, Carlson RG, Srinivasachar K, Sternson L, Higuchi T. Naphthalene-2,3-dicarboxaldehyde/cyanide ion: a rationally designed fluorogenic reagent for primary amines. Anal Chem 1987;59;1096-1101.
10. O'Shea T, Weber P, Bammel B, Lunte C, Lunte S. Monitoring excitatory amino acid release in vivo by microdialysis with capillary electrophoresis-electrochemistry. J Chromatogra 1992 608:189-195.
11. Rawls SM, McGinty JF. Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum. J Neurochem 1998;70:626-634.
12. Rawls SM, McGinty JF. Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study. J Pharmacol Exp Ther 1998;286:91-98.
13. Zhou SY, Zuo H, Stobaugh JF, Lunte CE, Lunte S. Continuous in vivo monitoring of amino acid neurotransmitters by microdialysis.sampling with on-line derivatization and capillary electrophoresis separation. Anal Chem 1995;67:594-599.
14. Rawls SM, Gomez T, Stagliano GW, Raffa RB. Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Meth 2006;53:291-295.
15. Sarnat HB, Netsky MG. The brain of the planarian as the ancestor of the human brain. Can J Neurol Sci 1985;12:296-302.
16. Carolei A, Margotta V, Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiol 1975;1:355-364.
17. Algeri S, Carolei A, Ferretti P, Gallone C, Palladini G, Venturini G: Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria. Comp Biochem Physiol C 1983;74:27-29.
18. Venturini G, Stocchi F, Margotta V, Ruggieri S, Bravi D, Bellantuono P, Palladini G. A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 1989;28: 1377-1382.
19. Palladini G, Ruggeri S, Stocchi F, De Pandis MF, Venturini G, Margotta V. A pharmacological study of cocaine activity in planaria. Comp Biochem Physiol C 1996:115:41-45.
20. Agata K, Watanabe K. Molecular and cellular aspects of planarian regeneration. Semin Cell Develop Biol 1999;10:377-383.
21. Passarelli F, Merante A, Pontieri F, Margotta V, Venturini G, Palladini G. Opioid-dopamine interaction in planaria: a behavioral study. Comp Biochem Physiol C 1999;124:51-55.
22. Agata K. The Zoological Society Prize. Molecular and cellular approaches to planarian regeneration. Zool Sci 2002;19:1391-1392.
23. Newmark PA, Sánchez Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat Rev Genet 2002;3:210-219.
24. Agata, K, Tanaka T, Kobayashi C, Kato K, Saitoh Y. Intercalary regeneration in planarians. Develop Dynam 2003;226:308-316.
25. Newmark PA, Reddien P, Cebria F, Sánchez; Alvarado A. Ingestion of bacterially expressed double-stranded RNA inhibits gene expression in planarians. Proc Natl Acad Sci (USA) 2003 100(Suppl 1): 11861-11865.
26. Raffa RB, Valdez JM, Holland LJ, Schulingkamp RJ. Energy-dependent UV light-induced disruption of (-)sulpiride antagonism of dopamine. Eur J Pharmacol 2000;406:R11-12.
27. Raffa RB, Valdez JM. Cocaine withdrawal in Planaria. Eur J Pharmacol 2001;430:143-145.
28. Raffa RB, Holland L, Schulingkamp RJ. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J Pharmacol Toxicol Meth 2001;45:223-226.
29. Raffa RB, Stagliano GW, Umeda S. k-Opioid withdrawal in Planaria. Neurosci Lett 2003; 349:139-142.
30. Umeda S, Stagliano GW, Raffa RB. Cocaine and k-Opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res 2004;1018:181-185.
31. Raffa RB, Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res 2005;1032:200-202.
32. Raffa RB, Martley AF. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res 2005;1031:138-140.
33. Johnson K, Churchill L, Klitenick MA, Hooks MS, Kalivas PW. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J Pharmacol Exp Ther 1996;277:1122-1131.
34. Rajendra JW, Lynch PR, Schofield PR. The glycine receptor. Pharmacol Ther 1997;73:121-146.
35. Bellis SL, Grosvenor W, Kass-Simon G, Rhoads DE. Chemoreception. in Hydra vulgaris (attenuata): initial characterization of two distinct binding sites for L-glutamic acid. Biochim Biophys Acta 1991; 1061:89-94.
36. Grosvenor W, Bellis SL, Kass-Simon G, Rhoads DE. Chemoreception, in hydra: specific binding of glutathione to a membrane fraction. Biochim Biophys Acta 1992;1117:120-125.
37. Kass-Simon G, Pannaccione A, Pierobon P. GABA and glutamate receptors are involved in modulating pacemaker activity in hydra. Comp Biochem Physiol A 2003;136:329-342.
38. Roberts E, Frankel S. gamma-Aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 1950;187:55-63.
39. Eriksson KS, Panula P. gamma-Aminobutyric acid in the nervous system of a planarian. J Comp Neurol 1994;345:528-536.
40. Mendonca,-Silva DL, Gardino PF, Kubrusly RC, De Mello FG, Noel F. Characterization of a GABAergic neurotransmission in adult Schistosoma, mansoni. Parasitol 2004; 129:137-146.